GLP-1 medications follow a dose-response relationship, meaning higher doses generally produce stronger metabolic effects
For the study, researchers randomly assigned 751 participants with obesity but not Type 2 diabetes to take either tirzepatide, aka Zepbound, or semaglutide, aka Wegovy, weekly, for 72 weeks
Results Eight trials were eligible, including a total of 68,572 patients, of whom 34,042 (49.6%) received GLP-1 RA treatment
Protein shakes and smoothies can be either helpful or counterproductive depending on their composition and how they fit into your overall nutrition planconsultation with a registered dietitian can provide personalized guidance
Compared to traditional injectable GLP-1 drugs, HS-10535's oral administration significantly improves patient adherence, which is crucial for enhancing the quality of life for diabetes patients
Some people lose 20 to 25 percent of their body weight, while others lose 8 to 10 percent